Subscribe To Our Free Newsletter |
Sell Aurobindo Pharma, target price Rs 485: Religare Broking
Aurobindo Pharma Ltd. key Products/Revenue Segments include Pharmaceuticals, Sale of services, Export Incentives and Scrap for the year ending 31-Mar-2022.